UBS Group
SLGC

UBS Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

UBS Group’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-186,853
Closed -$473K – 10435
2023
Q4 		$473K Buy
186,853
+71,567
+62% +$167K ﹤0.01% 5149
2023
Q3 		$276K Sell
115,286
-2,260
-2% -$5K ﹤0.01% 5127
2023
Q2 		$272K Buy
117,546
+45,899
+64% +$130K ﹤0.01% 5268
2023
Q1 		$183K Buy
71,647
+12,138
+20% +$34.8K ﹤0.01% 5454
2022
Q4 		$149K Buy
59,509
+49,504
+495% +$138K ﹤0.01% 5731
2022
Q3 		$29K Sell
10,005
-10,940
-52% -$46.1K ﹤0.01% 6938
2022
Q2 		$94K Sell
20,945
-104,557
-83% -$622K ﹤0.01% 5476
2022
Q1 		$1.01M Buy
125,502
+115,989
+1,219% +$1.02M ﹤0.01% 4092
2021
Q4 		$110K Buy
9,513
+4,863
+105% +$58.2K ﹤0.01% 6233
2021
Q3 		$58K Buy
+4,650
New +$52.4K ﹤0.01% 6219

UBS Group's SLGC Position: Q1 2024 in Review

UBS Group sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 186,853 shares — an estimated $473K sold.

UBS Group first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $1.01M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • UBS Group reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 186,853 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $473K.
  • UBS Group first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • UBS Group's SomaLogic, Inc. Class A Common Stock position peaked at $1.01M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.